Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy in Inpatient Cirrhotic Patients with Type 2 Diabetes
NCT01143948Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Jan 2011
- Primary completion
- Apr 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin glulisine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Cairo University. Primary endpoint: Optimal glycemic control in inpatient cirrhotics. Status: unknown.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01143948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143948.